全文获取类型
收费全文 | 936篇 |
免费 | 63篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 8篇 |
妇产科学 | 9篇 |
基础医学 | 210篇 |
口腔科学 | 7篇 |
临床医学 | 127篇 |
内科学 | 104篇 |
皮肤病学 | 14篇 |
神经病学 | 81篇 |
特种医学 | 26篇 |
外科学 | 143篇 |
综合类 | 17篇 |
一般理论 | 2篇 |
预防医学 | 95篇 |
眼科学 | 7篇 |
药学 | 66篇 |
肿瘤学 | 81篇 |
出版年
2023年 | 8篇 |
2021年 | 7篇 |
2019年 | 16篇 |
2018年 | 12篇 |
2017年 | 11篇 |
2015年 | 19篇 |
2014年 | 15篇 |
2013年 | 21篇 |
2012年 | 45篇 |
2011年 | 42篇 |
2010年 | 26篇 |
2009年 | 20篇 |
2008年 | 39篇 |
2007年 | 66篇 |
2006年 | 77篇 |
2005年 | 50篇 |
2004年 | 39篇 |
2003年 | 27篇 |
2002年 | 21篇 |
2001年 | 20篇 |
2000年 | 23篇 |
1999年 | 18篇 |
1998年 | 14篇 |
1997年 | 12篇 |
1996年 | 13篇 |
1995年 | 12篇 |
1994年 | 6篇 |
1993年 | 7篇 |
1992年 | 19篇 |
1991年 | 18篇 |
1990年 | 19篇 |
1989年 | 20篇 |
1988年 | 22篇 |
1987年 | 18篇 |
1986年 | 10篇 |
1985年 | 17篇 |
1984年 | 9篇 |
1983年 | 17篇 |
1982年 | 7篇 |
1979年 | 10篇 |
1976年 | 7篇 |
1975年 | 9篇 |
1974年 | 12篇 |
1973年 | 7篇 |
1972年 | 8篇 |
1971年 | 6篇 |
1970年 | 7篇 |
1968年 | 5篇 |
1967年 | 9篇 |
1966年 | 6篇 |
排序方式: 共有999条查询结果,搜索用时 15 毫秒
11.
P E Enterline J C McDonald A D McDonald L Davignon V Salter 《The New England journal of medicine》1973,288(22):1152-1155
12.
Tubbs RS Oakes WJ Salter EG Zehren SJ 《Anatomical science international / Japanese Association of Anatomists》2004,79(2):98-100
We report an adult male cadaver with persistence of the ductus arteriosus and a right retroesophageal artery. The retroesophageal artery was first appreciated as a retropharyngeal mass during the dissection of this area. Both the left and right vertebral arteries originated in normal fashion. The thoracic duct of our specimen drained into the junction of the left internal jugular and left subclavian veins. We believe this to be the first report of simultaneous right retroesophageal subclavian artery and patent ductus arteriosus. The anatomy and embryology of these two anomalies in the same specimen are discussed. 相似文献
13.
14.
15.
16.
17.
Peptide-conformed beta2m-free class I heavy chains are intermediates in generation of soluble HLA by the membrane-bound metalloproteinase 总被引:1,自引:0,他引:1
Demaria S DeVito-Haynes LD Salter RD Burlingham WJ Bushkin Y 《Human immunology》1999,60(12):1216-1226
Molecular mechanisms of soluble HLA-release by a membrane-bound metalloproteinase (MPase) are not defined. We have investigated the possibility that certain beta2-microglobulin (beta2m)-free heavy chains (HC) retain peptide-induced conformations before and after the cleavage by using mutant HLA-A2.242K HC with reduced affinity for beta2m. We show that dissociation of HC/beta2m complexes on the surface of C1R lymphoblastoid cells generates both conformed and non-conformed beta2m-free HC recognized by conformation-dependent antibodies. Conformed HC, having bound the HLA-A2-specific peptide HTLV-1 tax 11-19, can retain their proper conformations after dissociation of beta2m. Further, conformed and non-conformed surface beta2m-free HC are cleaved by the MPase, and some released HC preserve their conformations. Exogenous beta2m binds only to conformed HC, and protects them from cleavage as effectively as the MPase inhibitor BB-2116. We propose that soluble HLA-release requires generation of peptide-conformed beta2m-free HC intermediates on the cell surface, which are then cleaved by the MPase and in solution may reassociate with beta2m. Given the role of soluble HLA in the indirect allorecognition, the activity of this MPase may be important in transplant rejection. 相似文献
18.
19.
Reduced apoptosis and proliferation and increased Bcl-2 in residual breast cancer following preoperative chemotherapy 总被引:10,自引:0,他引:10
P.A. Ellis I.E. Smith S. Detre S.A. Burton J. Salter R. A'Hern G. Walsh S.R.D. Johnston M. Dowsett 《Breast cancer research and treatment》1998,48(2):107-116
Experimental laboratory data suggest that tumour growth is a balance between apoptosis and proliferation and that suppression of drug-induced apoptosis by oncogenes such as bcl-2 may be an important cause of intrinsic chemoresistance. The aims of this study were to assess the in vivo relationship of apoptosis to proliferation and Bcl-2 protein in human breast tumours both prior to chemotherapy and in the residual resistant cell population at the completion of treatment. We examined apoptotic index (AI), Ki67 and Bcl-2 protein expression in the tissue of 40 patients with operable breast cancer immediately before ECF preoperative chemotherapy, and in 20 of these patients with residual tumour, at the completion of treatment. There was a significant positive association between AI and Ki67 both before and after chemotherapy, and in their percentage change with treatment. In the residual specimens AI and Ki67 were significantly reduced compared with pre-treatment biopsies, while Bcl-2 expression showed a significant increase. No differences were seen in the pre-treatment levels of any of the variables measured between patients obtaining pathological complete response and those who did not, although numbers were small. These data suggest that apoptosis and proliferation are closely related in vivo. It is possible that the phenotype of reduced apoptosis and proliferation, and increased Bcl-2 may be associated with breast cancer cells resistant to cytotoxic chemotherapy, although this can only be proven by assessing larger numbers of patients in relation to pathological response. 相似文献
20.
Mitch Dowsett Steve R Ebbs J Michael Dixon Anthony Skene Clive Griffith Irene Boeddinghaus Janine Salter Simone Detre Margaret Hills Susan Ashley Stephen Francis Geraldine Walsh Ian E Smith 《Journal of clinical oncology》2005,23(11):2477-2492
PURPOSE: To investigate the relationships between biomarker changes in breast cancer during neoadjuvant (preoperative) endocrine therapy. PATIENTS AND METHODS: The IMPACT trial compared the preoperative use of tamoxifen with anastrozole alone or in combination in postmenopausal women (n = 330) with primary breast cancer. Biomarkers were measured in tumor biopsy specimens taken at baseline, and after 2 and 12 weeks of treatment. RESULTS: 52 (93%) of 56, 46 (85%) of 54, and 37 (84%) of 44 patients in the anastrozole, tamoxifen, and combination groups, respectively. There was a significantly greater suppression of Ki67 in the anastrozole-treated group than in the tamoxifen- or combination-treated groups, which is parallel to the greater efficacy seen for anastrozole over these two treatments in the Arimidex, Tamoxifen, Alone or in Combination adjuvant trial. A positive relationship was noted between estrogen-receptor level and Ki67 suppression in all patients. Ki67 was reduced to a greater extent in progesterone receptor-positive tumors compared with progesterone receptor-negative tumors. HER-2-negative tumors tended to show a greater reduction in Ki67 compared with HER-2-positive tumors, but the difference was only significant in the tamoxifen group after 2 weeks, and in the anastrozole group after 12 weeks. CONCLUSION: These results confirm the value of Ki67 as a molecular marker, and provide information regarding the relationships between treatment-induced changes in Ki67 and other important biomarkers. Studies such as this should help integrate agents targeted at growth factor signaling with endocrine agents in breast cancer. 相似文献